Seragon Biosciences, Inc. today announced the launch of RESTORIN(R) , an advanced nutraceutical for healthy aging. RESTORIN integrates a series of patented technologies from Harvard University, Mayo Clinic, and Scripps Research to boost cellular nicotinamide adenine dinucleotide (NAD+) levels and enhance senolytic stimulation. For decades, the intricate nature of aging has left scientists with many stones unturned in the field of aging intervention. The latest research has pinpointed senolytics